Performance Evaluation Of Convolutions And Atrous Convolutions In Deep Networks For Retinal Disease Segmentation On Optical Coherence Tomography Volumes

Affiliation auteurs!!!! Error affiliation !!!!
TitrePerformance Evaluation Of Convolutions And Atrous Convolutions In Deep Networks For Retinal Disease Segmentation On Optical Coherence Tomography Volumes
Type de publicationConference Paper
Year of Publication2020
AuteursAlsaih K, Yusoff MZ, Tang TB, Faye I, Eriaudeau FMPrime
Conference Name42ND ANNUAL INTERNATIONAL CONFERENCES OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY: ENABLING INNOVATIVE TECHNOLOGIES FOR GLOBAL HEALTHCARE EMBC'20
PublisherIEEE Engn Med & Biol Soc
Conference Location345 E 47TH ST, NEW YORK, NY 10017 USA
ISBN Number978-1-7281-1990-8
Mots-clésAtrous convolution, convolution, Optical Coherence Tomography, Retinal diseases segmentation
Résumé

The deterioration of the retina center could be the main reason for vision loss. Older people usually ranging from 50 years and above are exposed to age-related macular degeneration (AMD) disease that strikes the retina. The lack of human expertise to interpret the complexity in diagnosing diseases leads to the importance of developing an accurate method to detect and localize the targeted infection. Approaching the performance of ophthalmologists is the consistent main challenge in retinal disease segmentation. Artificial intelligence techniques have shown enormous achievement in various tasks in computer vision. This paper depicts an automated end-to-end deep neural network for retinal disease segmentation on optical coherence tomography (OCT) scans. The work proposed in this study shows the performance difference between convolution operations and atrous convolution operations. Three deep semantic segmentation architectures, namely U-net, Segnet, and Deeplabv3+, have been considered to evaluate the performance of varying convolution operations. Empirical outcomes show a competitive performance to the human level, with an average dice score of 0.73 for retinal diseases.